{Reference Type}: Case Reports
{Title}: Co-pathology may impact outcomes of amyloid-targeting treatments: clinicopathological results from two patients treated with aducanumab.
{Author}: VandeVrede L;La Joie R;Horiki S;Mundada NS;Koestler M;Hwang JH;Ljubenkov PA;Rojas JC;Rabinovici GD;Boxer AL;Seeley WW;
{Journal}: Acta Neuropathol
{Volume}: 146
{Issue}: 5
{Year}: 2023 11 19
{Factor}: 15.887
{DOI}: 10.1007/s00401-023-02631-8